• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含特殊 AT 的序列结合蛋白 1 促进结直肠癌的细胞生长和转移。

Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.

机构信息

Department of Medical Oncology, Second Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou 310000, Zhejiang Province, China.

出版信息

World J Gastroenterol. 2013 Apr 21;19(15):2331-9. doi: 10.3748/wjg.v19.i15.2331.

DOI:10.3748/wjg.v19.i15.2331
PMID:23613626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3631984/
Abstract

AIM

To evaluate the expression of special AT-rich sequence-binding protein 1 (SATB1) gene in colorectal cancer and its role in colorectal cancer cell proliferation and invasion.

METHODS

Immunohistochemistry was used to detect the protein expression of SATB1 in 30 colorectal cancer (CRC) tissue samples and pair-matched adjacent non-tumor samples. Cell growth was investigated after enhancing expression of SATB1. Wound-healing assay and Transwell assay were used to investigate the impact of SATB1 on migratory and invasive abilities of SW480 cells in vitro. Nude mice that received subcutaneous implantation or lateral tail vein were used to study the effects of SATB1 on tumor growth or metastasis in vivo.

RESULTS

SATB1 was over-expressed in CRC tissues and CRC cell lines. SATB1 promotes cell proliferation and cell cycle progression in CRC SW480 cells. SATB1 overexpression could promote cell growth in vivo. In addition, SATB1 could significantly raise the ability of cell migration and invasion in vitro and promote the ability of tumor metastasis in vivo. SATB1 could up-regulate matrix metalloproteases 2, 9, cyclin D1 and vimentin, meanwhile SATB1 could down-regulate E-cadherin in CRC.

CONCLUSION

SATB1 acts as a potential growth and metastasis promoter in CRC. SATB1 may be useful as a therapeutic target for CRC.

摘要

目的

评估富含特殊 AT 序列结合蛋白 1(SATB1)基因在结直肠癌中的表达及其在结直肠癌细胞增殖和侵袭中的作用。

方法

采用免疫组织化学方法检测 30 例结直肠癌(CRC)组织标本及其配对的相邻非肿瘤组织标本中 SATB1 的蛋白表达。增强 SATB1 的表达后,研究细胞生长情况。划痕愈合实验和 Transwell 实验用于研究 SATB1 对体外 SW480 细胞迁移和侵袭能力的影响。通过皮下植入或尾静脉注射裸鼠,研究 SATB1 对体内肿瘤生长或转移的影响。

结果

SATB1 在 CRC 组织和 CRC 细胞系中过度表达。SATB1 促进 CRC SW480 细胞的增殖和细胞周期进程。SATB1 过表达可促进体内细胞生长。此外,SATB1 可显著提高细胞在体外的迁移和侵袭能力,并促进体内肿瘤转移能力。SATB1 可上调基质金属蛋白酶 2、9、细胞周期蛋白 D1 和波形蛋白,同时下调 CRC 中的 E-钙黏蛋白。

结论

SATB1 作为 CRC 潜在的生长和转移促进因子。SATB1 可能是 CRC 治疗的一个有价值的靶点。

相似文献

1
Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.富含特殊 AT 的序列结合蛋白 1 促进结直肠癌的细胞生长和转移。
World J Gastroenterol. 2013 Apr 21;19(15):2331-9. doi: 10.3748/wjg.v19.i15.2331.
2
Expression of SATB1 promotes the growth and metastasis of colorectal cancer.SATB1的表达促进结直肠癌的生长和转移。
PLoS One. 2014 Jun 27;9(6):e100413. doi: 10.1371/journal.pone.0100413. eCollection 2014.
3
SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.SATB1通过调节上皮-间质转化促进前列腺癌转移。
Biomed Pharmacother. 2016 Apr;79:1-8. doi: 10.1016/j.biopha.2016.01.038. Epub 2016 Feb 9.
4
SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.SATB1 的表达与结直肠癌的体外和体内生物学行为相关。
PLoS One. 2013;8(1):e47902. doi: 10.1371/journal.pone.0047902. Epub 2013 Jan 11.
5
[Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].[APRIL在结肠癌细胞中的异常表达促进肿瘤生长和转移]
Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):249-55. doi: 10.3760/cma.j.issn.0253-3766.2013.04.003.
6
Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.富含AT序列的特异性结合蛋白2作为结肠癌细胞干性的负调节因子。
World J Gastroenterol. 2016 Oct 14;22(38):8528-8539. doi: 10.3748/wjg.v22.i38.8528.
7
SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.SATB1 敲低通过逆转 EMT 和抑制 MMP-9 抑制鼻咽癌细胞的增殖、侵袭和降低放化疗耐药性。
Int J Med Sci. 2021 Jan 1;18(1):42-52. doi: 10.7150/ijms.49792. eCollection 2021.
8
MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.MLLT10促进人类结直肠癌的肿瘤迁移、侵袭和转移。
Scand J Gastroenterol. 2018 Aug;53(8):964-971. doi: 10.1080/00365521.2018.1481521. Epub 2018 Aug 13.
9
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.SATB1 的上调促进肝癌的肿瘤生长和转移。
Liver Int. 2012 Aug;32(7):1064-78. doi: 10.1111/j.1478-3231.2012.02815.x. Epub 2012 May 14.
10
Vimentin affects colorectal cancer proliferation, invasion, and migration via regulated by activator protein 1.波形蛋白通过激活蛋白 1 调控影响结直肠癌细胞的增殖、侵袭和迁移。
J Cell Physiol. 2021 Nov;236(11):7591-7604. doi: 10.1002/jcp.30402. Epub 2021 May 27.

引用本文的文献

1
MSK1 promotes colorectal cancer metastasis by increasing Snail protein stability through USP5-mediated Snail deubiquitination.丝裂原和应激激活蛋白激酶1(MSK1)通过泛素特异性蛋白酶5(USP5)介导的Snail去泛素化增加Snail蛋白稳定性,从而促进结直肠癌转移。
Exp Mol Med. 2025 Apr;57(4):820-835. doi: 10.1038/s12276-025-01433-0. Epub 2025 Apr 1.
2
Expression of p16 and SATB1 in Invasive Ductal Breast Cancer - A Preliminary Study.p16和SATB1在乳腺浸润性导管癌中的表达——一项初步研究
In Vivo. 2018 Jul-Aug;32(4):731-736. doi: 10.21873/invivo.11301.
3
Expression of SATB1 and E-cad in tissues of patients with endometrial carcinoma and the relationship with clinicopathological features.SATB1和E-cad在子宫内膜癌患者组织中的表达及其与临床病理特征的关系。
Exp Ther Med. 2018 May;15(5):4339-4343. doi: 10.3892/etm.2018.5954. Epub 2018 Mar 13.
4
Effect of SATB1 silencing on the proliferation, invasion and apoptosis of TE-1 esophageal cancer cells.SATB1基因沉默对TE-1食管癌细胞增殖、侵袭及凋亡的影响。
Oncol Lett. 2017 May;13(5):2915-2920. doi: 10.3892/ol.2017.5854. Epub 2017 Mar 13.
5
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.胶质母细胞瘤细胞中SATB1抑制后细胞和分子抗肿瘤作用的分析
BMC Cancer. 2017 Jan 3;17(1):3. doi: 10.1186/s12885-016-3006-6.
6
Effect of silencing SATB1 on proliferation, invasion and apoptosis of A549 human lung adenocarcinoma cells.沉默SATB1对人肺腺癌细胞A549增殖、侵袭及凋亡的影响。
Oncol Lett. 2016 Nov;12(5):3818-3824. doi: 10.3892/ol.2016.5179. Epub 2016 Sep 22.
7
SATB1 expression is correlated with β-catenin associated epithelial-mesenchymal transition in colorectal cancer.SATB1表达与结直肠癌中β-连环蛋白相关的上皮-间质转化相关。
Cancer Biol Ther. 2016;17(3):254-61. doi: 10.1080/15384047.2016.1139239. Epub 2016 Jan 25.
8
SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.SATB1通过激活MYC促进胰腺癌的生长和侵袭。
Dig Dis Sci. 2015 Nov;60(11):3304-17. doi: 10.1007/s10620-015-3759-9. Epub 2015 Jun 25.
9
Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.携带靶向SATB1的短发夹RNA的溶瘤病毒可抑制前列腺癌的生长和转移。
Tumour Biol. 2015 Nov;36(11):9073-81. doi: 10.1007/s13277-015-3658-x. Epub 2015 Jun 19.
10
Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.SATB1 mRNA和SATB1蛋白在结直肠癌组织与正常组织中的表达模式差异。
Tumour Biol. 2015 Jun;36(6):4441-52. doi: 10.1007/s13277-015-3084-0. Epub 2015 Jan 21.

本文引用的文献

1
microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.miRNA-146a 靶向 L1 细胞黏附分子并抑制胃癌的转移潜能。
Mol Med Rep. 2012 Sep;6(3):501-6. doi: 10.3892/mmr.2012.946. Epub 2012 Jun 13.
2
Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition. Nigericin 通过抑制上皮-间质转化抑制结直肠癌转移。
World J Gastroenterol. 2012 Jun 7;18(21):2640-8. doi: 10.3748/wjg.v18.i21.2640.
3
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.SATB1 的上调促进肝癌的肿瘤生长和转移。
Liver Int. 2012 Aug;32(7):1064-78. doi: 10.1111/j.1478-3231.2012.02815.x. Epub 2012 May 14.
4
The SNP rs961253 in 20p12.3 is associated with colorectal cancer risk: a case-control study and a meta-analysis of the published literature.SNP rs961253 位于 20p12.3 与结直肠癌风险相关:病例对照研究和已发表文献的荟萃分析。
PLoS One. 2012;7(4):e34625. doi: 10.1371/journal.pone.0034625. Epub 2012 Apr 11.
5
Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors.局部进展期结直肠癌多脏器联合切除的结果:T4 期肿瘤的临床病理分析。
World J Surg Oncol. 2012 Feb 15;10:39. doi: 10.1186/1477-7819-10-39.
6
Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.贝伐珠单抗联合一线化疗方案治疗 Medicare 医保Ⅳ期结直肠癌患者的疗效。
J Clin Oncol. 2012 Feb 20;30(6):608-15. doi: 10.1200/JCO.2011.38.9650. Epub 2012 Jan 17.
7
Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer.凋亡敏感基因表达对直肠癌的预后作用。
World J Gastroenterol. 2011 Nov 28;17(44):4905-10. doi: 10.3748/wjg.v17.i44.4905.
8
Correlation of SATB1 overexpression with the progression of human rectal cancer.SATB1 过表达与人直肠癌进展的相关性。
Int J Colorectal Dis. 2012 Feb;27(2):143-50. doi: 10.1007/s00384-011-1302-9. Epub 2011 Aug 26.
9
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.西妥昔单抗联合伊立替康、氟尿嘧啶和亚叶酸钙作为转移性结直肠癌的一线治疗:根据肿瘤 KRAS 和 BRAF 突变状态更新的总生存分析。
J Clin Oncol. 2011 May 20;29(15):2011-9. doi: 10.1200/JCO.2010.33.5091. Epub 2011 Apr 18.
10
Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.中国结直肠癌患者 K-ras 和 BRAF 突变的临床意义。
World J Gastroenterol. 2011 Feb 14;17(6):809-16. doi: 10.3748/wjg.v17.i6.809.